Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes
posted 02/26/03

With a HbA_1c of 6%, there is a 75% increased risk of microvascular complications of type 2 diabetes

The use of fasting plasma glucose (FPG) level 7.0 mmol/l leads to underdiagnosis of type 2 diabetes compared with the oral glucose tolerance test (OGTT). The OGTT is of limited use for population screening. Most of the increase in cardiovascular risk in relation to increasing blood glucose occurs before the threshold at which the diagnosis of type 2 diabetes is made. The aim of this study was to evaluate the use of HbA_1c and FPG as predictors of type 2 diabetes and cardiovascular risk and, accordingly, to develop a rational approach to screening for abnormalities of glucose tolerance.

For the study OGTT and measurement of HbA_1c and FPG levels were performed in 505 subjects screened for type 2 diabetes. Anthropomorphic measurements were obtained. A cardiovascular risk factor questionnaire was completed.

The subjects were aged 19–88 years (mean 53.8). The incidence of type 2 diabetes was 10.4% based on the OGTT and 4% based on an FPG level 7.0 mmol/l. Using high-performance liquid chromatography (HPLC), HbA_1c of <4.7 and 6.2% predicted with certainty the absence or presence of type 2 diabetes as defined by the OGTT. The corresponding cutoffs were <5.0 and 6.8% for HbA_1c (DCA2000 HPLC device; Bayer Diagnostics, Mulgrave, Australia) and <4.7 and 6.4 mmol/l for FPG. However, 75–85% of subjects in each case had intermediate values, which were therefore nondiagnostic. Cardiovascular risk increased at least 2.2 times at an HbA_1c level 6.2% (by HPLC), 1.8–2.2 times at an HbA_1c level of 5.6–6.1% (by HPLC), 2 times at an FPG level 6.4 mmol/l, and 1.7–1.9 times at an FPG level of 5.6–6.3 mmol/l.

From the results it was concluded that measurement of FPG and HbA_1c levels will diagnose or exclude type 2 diabetes with certainty in a minority (15%) of people. There is a continuous relationship between FPG and HbA_1c and cardiovascular risk. Accordingly, we propose that there is a rational basis for using either FPG and HbA_1c for purposes of screening and assigning risk. Individuals with an HbA_1c level of 5.6–6.1% and an FPG level of 5.6–6.3 mmol/l are at greatest risk for cardiovascular disease and should be targeted for further evaluation.

Source: Diabetes In Control Dot Com: Diabetes Care 26:485-490, 2003.

February News Article Index

Home - Table of Contents - Donate Now - About Diabetes - Warning Signs - Complications - Screening Test - Diabetes Terms - Site Search - Meet Mr. Diabetes®  -  Wake Up And Walk® Tour - Latest News - Headlines & News Stories - Health & Fitness - About Us - FAQ - Research Form - -  Message Board - Privacy Policy - Legal Notices - How to Contact Us - Comments form - Suggestion Form - Our E-Mail Addresses - Our Address and Phone Numbers - Links - Contact Us